AN-019
AN-019 is a Bcr-Abl kinase inhibitor. AN-019 has antitumor activity[1].
Product Specifications
CAS Number
879507-25-2
Product Name Alternative
NRC-AN-019
UNSPSC
12352005
Target
Bcr-Abl
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/an-019.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4
Molecular Formula
C25H17F6N5O
Molecular Weight
517.43
References & Citations
[1]Amala K, et al. Design, synthesis and preclinical evaluation of NRC-AN-019. Int J Oncol. 2013 Jan;42 (1) :168-78
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E16FHK138-100 100 Tests
Alexa Fluor® 647 anti-human CD138 (Syndecan-1)
Sign In for Pricing
View Details 221665-01 50 µL
CGREF1 (Cell Growth Regulator with EF hand Domain Protein 1, Cell Growth Regulatory Gene 11 Protein, Hydrophobestin, CGR11) discontinued
Sign In for Pricing
View Details 221665-02 100 µL
CGREF1 (Cell Growth Regulator with EF hand Domain Protein 1, Cell Growth Regulatory Gene 11 Protein, Hydrophobestin, CGR11) discontinued
Sign In for Pricing
View Details